Book contents
- Mood Disorders
- Mood Disorders
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 General
- Section 2 Anatomical Studies
- Section 3 Functional and Neurochemical Brain Studies
- Section 4 Novel Approaches in Brain Imaging
- Chapter 11 Imaging Genetic and Epigenetic Markers in Mood Disorders
- Chapter 12 fMRI Neurofeedback as Treatment for Depression
- Chapter 13 Functional Near-Infrared Spectroscopy Studies in Mood Disorders
- Chapter 14 Electrophysiological Biomarkers for Mood Disorders
- Chapter 15 Magnetoencephalography Studies in Mood Disorders
- Chapter 16 An Overview of Machine Learning Applications in Mood Disorders
- Section 5 Therapeutic Applications of Neuroimaging in Mood Disorders
- Index
- Plate Section (PDF Only)
- References
Chapter 12 - fMRI Neurofeedback as Treatment for Depression
from Section 4 - Novel Approaches in Brain Imaging
Published online by Cambridge University Press: 12 January 2021
- Mood Disorders
- Mood Disorders
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 General
- Section 2 Anatomical Studies
- Section 3 Functional and Neurochemical Brain Studies
- Section 4 Novel Approaches in Brain Imaging
- Chapter 11 Imaging Genetic and Epigenetic Markers in Mood Disorders
- Chapter 12 fMRI Neurofeedback as Treatment for Depression
- Chapter 13 Functional Near-Infrared Spectroscopy Studies in Mood Disorders
- Chapter 14 Electrophysiological Biomarkers for Mood Disorders
- Chapter 15 Magnetoencephalography Studies in Mood Disorders
- Chapter 16 An Overview of Machine Learning Applications in Mood Disorders
- Section 5 Therapeutic Applications of Neuroimaging in Mood Disorders
- Index
- Plate Section (PDF Only)
- References
Summary
We urgently need new therapeutic strategies for depression (1). Depression is one of the top three causes of disability in the global disease burden statistic, affecting up to 15% of the population of high-income countries and with increasing prevalence also in low- and middle-income countries. This comes at huge socioeconomic and healthcare costs, especially because a large number of patients develop chronic illness, regardless of the available treatments that are effective for the majority of patients. The mainstay of current management are pharmacological and psychological/psychosocial interventions, and recent innovation has been particularly active in the field of physical interventions, adding transcranial magnetic stimulation (TMS) to the repertoire.
- Type
- Chapter
- Information
- Mood DisordersBrain Imaging and Therapeutic Implications, pp. 151 - 165Publisher: Cambridge University PressPrint publication year: 2021